AKER CHRISTOPHER RAY (Sr. VP & General Counsel) received a stock award from REGULUS THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/10/2025ACC: 0000950170-25-004270
Officer· Sr. VP & General Counsel
Since Jan 2019
+84.13K
Net shares
Net buyer
$113.4K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
84.13K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+66.63K
Price / share
$1.36
Trade value
$90.61K
% of position
735.7%
1/9/2025
9.06K→75.68K
Common Stock
Direct
Shares
+17.50K
Price / share
$1.30
Trade value
$22.75K
% of position
23.1%
1/9/2025
75.68K→93.18K
Total
Net shares
+84.13K
Net value
$113.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2025 | A · Award | +66.63K | $1.36 | $90.61K | 735.7% | 9.06K | 75.68K |
| Common Stock Direct | 1/9/2025 | A · Award | +17.50K | $1.30 | $22.75K | 23.1% | 75.68K | 93.18K |
| Total | +84.13K | $113.36K | ||||||
Derivative Transactions0
No derivative transactions reported